Trial site
Santiago
- 17running trials
- 21closed trials
The trials here
What the 38 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)6 trials
- COPD5 trials
- Asthma4 trials
- Multiple sclerosis4 trials
- Hidradenitis suppurativa3 trials
- Alopecia areata1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Chronic spontaneous urticaria1 trial
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
- Coeliac disease1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- and 12 more
- Phase
- Phase 219 trials
- Phase 316 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed15 trials
- Active, not recruiting13 trials
- Terminated6 trials
- Recruiting4 trials
- Lead sponsor
- Sanofi38 trials
Running trials
Recruiting
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD2 recruiting
- Hidradenitis suppurativa1 recruiting
Closed trials
Terminated
Completed
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Completed
Terminated
Completed
A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis
Completed
A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa
Completed
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma
Completed
Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma
Completed
Completed
Terminated
Terminated
Terminated
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026